Home
Conditions
Fatty Liver

Clinical trial condition

Fatty Liver

Explore clinical trials studying Fatty Liver. Study availability and eligibility vary by location and protocol.

952 public trials 145 recruiting studies

Refine in advanced search Browse all conditions

Fatty Liver trial results

Completed

Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASH

NCT00706537

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Pfizer Investigational Site Anaheim, California, United States

Pfizer Investigational Site Anaheim, California, United States

Pfizer Investigational Site Durham, North Carolina, United States

View Trial Details

Completed

Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers

NCT00856869

Conditions: Digestive System Diseases, Fatty Liver, Fibrosis, +7 more
Locations: UMHAPT St. Ivan Rilski's University Hospital Sofia, Bulgaria

View Trial Details

Completed

Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis

NCT00509418

Conditions: Behavior, Digestive System Diseases, Fatty Liver, +4 more
Locations: National Institute of Gastroenterology Vedado, La Habana, Cuba

View Trial Details

Completed

Fatty Liver and Obstructive Sleep Apnea

NCT00730873

Conditions: Apnea, Digestive System Diseases, Dyssomnias, +12 more
Locations: The pulmonary institute, Asaf Harofeh Medical Center Ẕerifin, Israel

View Trial Details

Completed

Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)

NCT00655018

Conditions: Body Weight, Body Weight Changes, Digestive System Diseases, +14 more
Locations: Dept. Of HepatoGastoEnterology and Nutrition, Liver Unit Rome, Italy

View Trial Details

Completed

Leptin to Treat Lipodystrophy

NCT00005905

Conditions: Diabetes Mellitus, Digestive System Diseases, Dyslipidemias, +14 more
Locations: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States

View Trial Details

Completed

Phase I Trial of Silymarin for Chronic Liver Diseases

NCT00389376

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +11 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

NCT06947304

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +5 more
Locations: University of Missouri Columbia, Missouri, United States

View Trial Details

Active, Not Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and White/European Ancestry

NCT07335198

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: GSK Investigational Site Auckland, New Zealand

View Trial Details

Active, Not Recruiting

Effect of a GnRH Analog on Hepatic Steatosis

NCT06523530

Conditions: Digestive System Diseases, Endometriosis, Fatty Liver, +13 more
Locations: 424 General Military Hospital Thessaloniki, Greece

1st Department of Obstetrics and Gynecology, School of Medicine, Aristotle University of Thessaloniki Thessaloniki, Greece

View Trial Details

Fatty Liver

Fatty Liver trial results

Related conditions